Prot# NU 07C3 / AVF3865ss: A Phase II Study of Bevacizumab and Erlotinib after Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma Without MGMT Promoter Methylation

Project: Research project

Project Details

StatusFinished
Effective start/end date6/30/086/30/18

Funding

  • Genentech, Inc. (NU 07C3 / AVF3865ss)